Home > Financial Ratios > MARKSANS PHARMA

MARKSANS PHARMA
EBIT Growth

    Back to All Ratios
MARKSANS PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for MARKSANS PHARMA
Please provide your vote to see the results

MARKSANS PHARMA Last 5 Year EBIT Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EBIT Growth(%) 25.3635.48-17.4786.9345.59

What is the latest EBIT Growth ratio of MARKSANS PHARMA ?

The latest EBIT Growth ratio of MARKSANS PHARMA is 25.36 based on Mar2024 Consolidated results.
Year EBIT Growth
Mar202425.36
Mar202335.48
Mar2022-17.47
Mar202186.93
Mar202045.59

How is EBIT Growth of MARKSANS PHARMA Trending?

Years EBIT Growth % Change
Mar2024 25.36
-28.52
Mar2023 35.48
Positive
Mar2022 -17.47
Negative
Mar2021 86.93
90.68
Mar2020 45.59 -

Other Financial Ratios of MARKSANS PHARMA


Compare EBIT Growth ratio of peers of MARKSANS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MARKSANS PHARMA ₹11,459.2 Cr -4.5% -12.9% 62.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹437,135.0 Cr 2.6% -1.1% 38.3% Stock Analytics
DIVIS LABORATORIES ₹153,074.0 Cr -3.8% -1.9% 60.1% Stock Analytics
CIPLA ₹114,019.0 Cr -2.4% -5.2% 10.6% Stock Analytics
DR REDDYS LABORATORIES ₹102,192.0 Cr -5.9% -9.6% 14.5% Stock Analytics
ZYDUS LIFESCIENCES ₹96,256.3 Cr -3.9% -0.3% 40.6% Stock Analytics


MARKSANS PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MARKSANS PHARMA

-4.5%

-12.9%

62.5%

SENSEX

-0.6%

-2.9%

6.3%


You may also like the below Video Courses